Recent advances in exosome-based nanovehicles as RNA interference therapeutic carriers
RNA interference (RNAi) therapeutics (siRNA, miRNA, etc.) represent an emerging medicinal remedy for a variety of ailments. However, their low serum stability and low cellular uptake signi cantly restrict their clinical applications. Exosomes are biologically derived nanodimensional vesicle ranging from a few nanometers to a hundred. In the last few years, several reports have been published demonstrating the emerging applications of these exogenous membrane vesicles, particularly in carrying different RNAi ther- apeutics to adjacent or distant targeted cells. In this report, we explored the numerous aspects of exosomes from structure to clinical implications with special emphasis on their application in delivering RNAi-based therapeutics. siRNA and miRNA have attracted great interest in recent years due to their speci c applica- tion in treating many complex diseases including cancer. We highlight strategies to obviate the challenges of their low bioavailability for gene therapy.
Citation : Maheshwari, R. Tekade, M., Gondaliya, P., Kalia, K., D’Emanuele, A., Tekade, R.K. (2017) Recent advances in exosome-based nanovehicles as RNA interference therapeutic carriers. Nanomedicine, 12 (21), pp. 2653-2675.
ISSN : 1743-5889
Peer Reviewed : Yes
- Leicester School of Pharmacy